- Corporate Officers - F
- Flynn Karen
Insider Trading History of Flynn Karen
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Flynn Karen since 2013.
This trader's CIK number is 1553599.
At the time of last reporting, Flynn Karen was the Chief Commercial Officer of Catalent, Inc.. (stock ticker symbol CTLT).
Also see all insider trading activities at Catalent, Inc..
Note that in the past
Flynn Karen also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Catalent, Inc. (CTLT) by Flynn Karen
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | CTLT | 0 | $0 | 2,472 | $288,334 | 0 | $0 |
| 2021 | CTLT | 0 | $0 | 2,577 | $288,665 | 0 | $0 |
Yearly summary of insider trading at West Pharmaceutical Services Inc (WST) by Flynn Karen
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | WST | 0 | $0 | 20,458 | $2,377,833 | 20,458 | $474,257 |
| 2016 | WST | 0 | $0 | 14,581 | $1,214,305 | 0 | $0 |
| 2015 | WST | 0 | $0 | 23,020 | $1,411,460 | 23,020 | $456,535 |
| 2013 | WST | 0 | $0 | 5,500 | $262,625 | 5,500 | $125,895 |
Yearly summary of insider trading at Recro Pharma, Inc. (REPH) by Flynn Karen
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | REPH | 0 | $0 | 0 | $0 | 13,274 | $0 |
| 2016 | REPH | 800 | $5,364 | 0 | $0 | 0 | $0 |
Insider trading activities at 3 companies by Flynn Karen:
1. Catalent, Inc. (CTLT)
2. West Pharmaceutical Services Inc (WST)
3. Recro Pharma, Inc. (REPH)
Table 1. Insider trading of Catalent, Inc. (CTLT) by Flynn Karen
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-01-10 | CTLT | Sale | 2,472 | 116.64 | 288,334 |
| 2021-01-11 | CTLT | Sale | 2,478 | 112.32 | 278,328 |
| 2021-01-04 | CTLT | Sale | 99 | 104.42 | 10,337 |
Table 2. Insider trading of West Pharmaceutical Services Inc (WST) by Flynn Karen
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-08-07 | WST | Option Ex | 20,458 | 23.18 | 474,257 |
| 2018-08-07 | WST | Sale | 20,458 | 116.23 | 2,377,833 |
| 2016-09-06 | WST | Sale | 14,581 | 83.28 | 1,214,305 |
| 2015-11-10 | WST | Option Ex | 18,020 | 20.88 | 376,311 |
| 2015-11-10 | WST | Sale | 18,020 | 63.03 | 1,135,728 |
| 2015-05-22 | WST | Option Ex | 3,091 | 16.05 | 49,595 |
| 2015-05-22 | WST | Sale | 3,091 | 55.24 | 170,737 |
| 2015-05-18 | WST | Option Ex | 1,909 | 16.05 | 30,629 |
| 2015-05-18 | WST | Sale | 1,909 | 55.00 | 104,995 |
| 2013-11-19 | WST | Sale | 5,500 | 47.75 | 262,625 |
| 2013-11-19 | WST | Option Ex | 5,500 | 22.89 | 125,895 |
Table 3. Insider trading of Recro Pharma, Inc. (REPH) by Flynn Karen
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-05-12 | REPH | Option Ex | 13,274 | .00 | 0 |
| 2016-12-16 | REPH | Buy | 800 | 6.71 | 5,364 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Flynn Karen
(Chief Commercial Officer of Catalent, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.